Advanced Filters
noise

crohns-disease Clinical Trials

A listing of crohns-disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 279 clinical trials
K Katha Makwana

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

The purpose of this research study is to evaluate what type of treatment will be beneficial for people with Crohn's disease and difficult to treat inflammation in the small bowel. Current therapies are used to control the inflammation due to Crohn's disease in your digestive tract. In some patients, those …

18 - 80 years of age All Phase 2
M Mahroukh Rafii

Threonine Requirement in Adult Males With Crohn's Disease Using IAAO

The goal of the current study is to measure the requirement for threonine in patients with CD using the IAAO method and compare the requirement to previously determined threonine requirement estimated in young adults using the IAAO technique. It is hypothesize that the requirement for threonine in patients with CD …

18 - 49 years of age Male Phase N/A
Q Qiao Yu, PhD

Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures

Crohn's disease (CD) is an inflammatory bowel disease characterized by chronic ulcers, strictures, and penetrating lesions in the intestinal tract. In the early stages of the disease, inflammation and ulcers are the primary manifestations. However, as the disease progresses and recurs over the years, even with medication treatment, 30%-50% of …

18 - 75 years of age All Phase N/A
B Byong Duk Ye, MD, PhD

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

This study will compare the efficacy and safety of TDM (therapeutic drug monitoring)-based infliximab (CT-P13, RemsimaTM) intravenous therapy compared with the standard infliximab (RemsimaTM) intravenous therapy for patients with active perianal fistulzing Crohn's disease.

19 - 80 years of age All Phase 4
W Wei Wang

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

The goal of this observational study is to evaluate the effectiveness and safety of exclusive enteral nutrition (EEN) in adults with active Crohn's disease (CD), particularly in patients with complicated disease such as stricturing disease, enteric fistula, and intra-abdominal abscess. The main questions it aims to answer are: What is …

18 years of age All Phase N/A
M Mei Wang

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

This study intends to select patients with confirmed moderate-to-severe Crohn's disease (CD) and obstructive symptoms of intestinal stenosis, who have clear evidence of lumen stenosis caused by the disease itself through radiography or endoscopy. After the informed consent of the patients, comprehensive drug therapy with ustekinumab as the mainstay was …

18 - 65 years of age All Phase N/A
B Bénédicte CARON, MD

Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease

Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal (GI) tract. CD is a common inflammatory bowel disease (IBD), frequent (150,000 patients in France and 1.5 million in Europe), disabling and incurable. The environmental factors, and in particular diet, play a major role in the pathogenesis of CD. …

18 - 65 years of age All Phase N/A
F Frederik D Thrane, MD

Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose Crohn's disease instead of colonoscopy and a small bowel examination (either MRI or camera pill) in patients aged 18-40 years suspected of having Crohn's disease. The main …

18 - 40 years of age All Phase N/A
C Claudia Musat

DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

This is a double-blind, randomized, placebo-controlled, sequential cohort, ascending dose clinical trial to evaluate the safety and determine the efficacy of ascending doses of DB-3Q for the treatment of Perianal Fistulizing Crohn's Disease.

18 - 75 years of age All Phase 2
O Onuma Sattayalertyanyong

Validation of Scoring Systems for Differentiating Intestinal Tuberculosis from Crohn's Disease

Differentiating CD from intestinal tuberculosis (ITB) is difficult due to the low sensitivities of currently available diagnostic tests. The Asia-Pacific guideline recommends anti-tuberculous therapy (ATT) for 8-12 weeks in patients with diagnostic uncertainty due to the risk of disseminated tuberculosis if patients with ITB are misdiagnosed with CD, and are …

18 years of age All Phase N/A

Simplify language using AI